Time-course regression analyses demonstrated that TSSK1B WT induces slower tumor growth and considerably smaller tumor burden compared to the control and TSSK1B mutant (T174A), without significant toxicity or weight loss (Fig. 6D–F). Here, TSSK1B is linked to neoplasm.